Literature DB >> 23867234

Cuprizone short-term exposure: astrocytic IL-6 activation and behavioral changes relevant to psychosis.

Tomoaki Tezuka1, Makoto Tamura, Mari A Kondo, Masaki Sakaue, Kinya Okada, Kana Takemoto, Atsushi Fukunari, Keiko Miwa, Hiromitsu Ohzeki, Shin-ichi Kano, Hiroshi Yasumatsu, Akira Sawa, Yasushi Kajii.   

Abstract

A growing body of evidence suggests the involvement of inflammatory processes in the pathophysiology of schizophrenia. Four- to 8-week exposure to cuprizone, a copper chelator, causes robust demyelination and has been used to build a model for multiple sclerosis. In contrast, we report here the effects of 1-week cuprizone exposure in mice. This short-term cuprizone exposure elicits behavioral changes that include augmented responsiveness to methamphetamine and phencyclidine, as well as impaired working memory. The cellular effects of 1-week cuprizone exposure differ substantially from the longer-term exposure; perturbation of astrocytes and microglia is induced without any sign of demyelination. Furthermore, the proinflammatory cytokine interleukin-6 was significantly up-regulated in glial fibrillary acidic protein (GFAP)-positive cells. We propose that this cuprizone short-term exposure may offer a model to study some aspects of biology relevant to schizophrenia and related conditions.
© 2013.

Entities:  

Keywords:  Astrocyte; Cytokine; Inflammation; Interleukin-6; Schizophrenia

Mesh:

Substances:

Year:  2013        PMID: 23867234      PMCID: PMC3936339          DOI: 10.1016/j.nbd.2013.07.003

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  46 in total

1.  A noncompetitive BACE1 inhibitor TAK-070 ameliorates Abeta pathology and behavioral deficits in a mouse model of Alzheimer's disease.

Authors:  Hiroaki Fukumoto; Hideki Takahashi; Naoki Tarui; Junji Matsui; Taisuke Tomita; Mitsuhiro Hirode; Masumi Sagayama; Ryouta Maeda; Makiko Kawamoto; Kazuko Hirai; Jun Terauchi; Yasufumi Sakura; Mitsuru Kakihana; Kaneyoshi Kato; Takeshi Iwatsubo; Masaomi Miyamoto
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

Review 2.  Astrocytes and microglia: responses to neuropathological conditions.

Authors:  Sarika Singh; Supriya Swarnkar; Poonam Goswami; Chandishwar Nath
Journal:  Int J Neurosci       Date:  2011-08-09       Impact factor: 2.292

3.  Inhibition of 5-lipoxygenase activity in mice during cuprizone-induced demyelination attenuates neuroinflammation, motor dysfunction and axonal damage.

Authors:  K Yoshikawa; S Palumbo; C D Toscano; F Bosetti
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2011-05-08       Impact factor: 4.006

4.  Copper and zinc dismetabolism in the mouse brain upon chronic cuprizone treatment.

Authors:  P Zatta; M Raso; P Zambenedetti; W Wittkowski; L Messori; F Piccioli; P L Mauri; M Beltramini
Journal:  Cell Mol Life Sci       Date:  2005-07       Impact factor: 9.261

Review 5.  Mechanisms underlying inflammation in neurodegeneration.

Authors:  Christopher K Glass; Kaoru Saijo; Beate Winner; Maria Carolina Marchetto; Fred H Gage
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

6.  Neuroinflammation in schizophrenia-related psychosis: a PET study.

Authors:  Janine Doorduin; Erik F J de Vries; Antoon T M Willemsen; Jan Cees de Groot; Rudi A Dierckx; Hans C Klein
Journal:  J Nucl Med       Date:  2009-10-16       Impact factor: 10.057

7.  Common variants on chromosome 6p22.1 are associated with schizophrenia.

Authors:  Jianxin Shi; Douglas F Levinson; Jubao Duan; Alan R Sanders; Yonglan Zheng; Itsik Pe'er; Frank Dudbridge; Peter A Holmans; Alice S Whittemore; Bryan J Mowry; Ann Olincy; Farooq Amin; C Robert Cloninger; Jeremy M Silverman; Nancy G Buccola; William F Byerley; Donald W Black; Raymond R Crowe; Jorge R Oksenberg; Daniel B Mirel; Kenneth S Kendler; Robert Freedman; Pablo V Gejman
Journal:  Nature       Date:  2009-07-01       Impact factor: 49.962

8.  Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review.

Authors:  Stéphane Potvin; Emmanuel Stip; Amir A Sepehry; Alain Gendron; Ramatoulaye Bah; Edouard Kouassi
Journal:  Biol Psychiatry       Date:  2007-11-19       Impact factor: 13.382

9.  Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes.

Authors:  L Xiao; H Xu; Y Zhang; Z Wei; J He; W Jiang; X Li; L E Dyck; R M Devon; Y Deng; X M Li
Journal:  Mol Psychiatry       Date:  2007-08-07       Impact factor: 15.992

10.  Region-specific susceptibilities to cuprizone-induced lesions in the mouse forebrain: Implications for the pathophysiology of schizophrenia.

Authors:  Hong-Ju Yang; Haitao Wang; Yanbo Zhang; Lan Xiao; Richard W Clough; Ronald Browning; Xin-Min Li; Haiyun Xu
Journal:  Brain Res       Date:  2009-03-21       Impact factor: 3.252

View more
  23 in total

1.  Anti-inflammatory Effect of Astaxanthin on the Sickness Behavior Induced by Diabetes Mellitus.

Authors:  Chang-jiang Ying; Fang Zhang; Xiao-yan Zhou; Xiao-tong Hu; Jing Chen; Xiang-ru Wen; Ying Sun; Kui-yang Zheng; Ren-xian Tang; Yuan-jian Song
Journal:  Cell Mol Neurobiol       Date:  2015-05-14       Impact factor: 5.046

Review 2.  Glial modulators as potential treatments of psychostimulant abuse.

Authors:  Patrick M Beardsley; Kurt F Hauser
Journal:  Adv Pharmacol       Date:  2014

3.  Adenosine Promotes the Recovery of Mice from the Cuprizone-Induced Behavioral and Morphological Changes while Effecting on Microglia and Inflammatory Cytokines in the Brain.

Authors:  Jinling Zhang; Liu Yang; Zeman Fang; Jiming Kong; Qingjun Huang; Haiyun Xu
Journal:  J Neuroimmune Pharmacol       Date:  2018-08-01       Impact factor: 4.147

4.  Brain metabolite changes in subcortical regions after exposure to cuprizone for 6 weeks: potential implications for schizophrenia.

Authors:  Gen Yan; Yinghua Xuan; Zhuozhi Dai; Zhiwei Shen; Guishan Zhang; Haiyun Xu; Renhua Wu
Journal:  Neurochem Res       Date:  2014-10-28       Impact factor: 3.996

5.  Chronic phencyclidine induces inflammatory responses and activates GSK3β in mice.

Authors:  Shenghua Zhu; Hongxing Wang; Ruoyang Shi; Ruiguo Zhang; Junhui Wang; Lynda Kong; Yingxia Sun; Jue He; Jiming Kong; Jun-Feng Wang; Xin-Min Li
Journal:  Neurochem Res       Date:  2014-10-01       Impact factor: 3.996

6.  Dimensional assessment of behavioral changes in the cuprizone short-term exposure model for psychosis.

Authors:  Mari A Kondo; Daisuke Fukudome; Dani R Smith; Michela Gallagher; Atsushi Kamiya; Akira Sawa
Journal:  Neurosci Res       Date:  2016-02-08       Impact factor: 3.304

Review 7.  Behavioral sequelae of astrocyte dysfunction: focus on animal models of schizophrenia.

Authors:  Meng Xia; Sofya Abazyan; Yan Jouroukhin; Mikhail Pletnikov
Journal:  Schizophr Res       Date:  2014-11-20       Impact factor: 4.939

8.  Neuronal copper homeostasis susceptibility by genetic defects in dysbindin, a schizophrenia susceptibility factor.

Authors:  Avanti Gokhale; Alysia Vrailas-Mortimer; Jennifer Larimore; Heather S Comstra; Stephanie A Zlatic; Erica Werner; Daniel F Manvich; P Michael Iuvone; David Weinshenker; Victor Faundez
Journal:  Hum Mol Genet       Date:  2015-07-21       Impact factor: 6.150

9.  Translocator protein (TSPO) and stress cascades in mouse models of psychosis with inflammatory disturbances.

Authors:  Daisuke Fukudome; Lindsay N Hayes; Travis E Faust; Catherine A Foss; Mari A Kondo; Brian J Lee; Atsushi Saito; Shin-Ichi Kano; Jennifer M Coughlin; Atsushi Kamiya; Martin G Pomper; Akira Sawa; Minae Niwa
Journal:  Schizophr Res       Date:  2018-02-03       Impact factor: 4.939

10.  Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination.

Authors:  SunJa Kim; Jacek Bielawski; Hyunmin Yang; Yu Kong; Beiyan Zhou; Jianrong Li
Journal:  Glia       Date:  2017-11-29       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.